DUSA Pharmaceuticals And New England Compounding Center Announce Favorable Settlement In Compounding Pharmacy Suit

DUSA Pharmaceuticals, Inc.® (NASDAQ: DUSA) and New England Compounding Center (NECC) announced today that they have settled their respective claims against each other to end the lawsuit filed by DUSA in December of 2004.

MORE ON THIS TOPIC